Authors: HAARDT MJ BERNE C DORANGE C SLAMA G SELAM JL

Citation: Mj. Haardt et al., EFFICACY AND INDICATIONS OF CSII REVISITED - THE HOTEL-DIEU COHORT, Diabetic medicine, 14(5), 1997, pp. 407-408

Authors: SCAVINI M GALLI L REICH S EATON RP CHARLES MA DUNN FL MICOSSI P TORRI M PETRELLA G GALIMBERTI G CRISTALLO M VAI S POZZA G OLSEN C TURNER D NOLLEMAN C LAVINTOMPKINS J SELAM JL HAARDT MJ DORANGE C JEANDIDIER N ORTEGA F BOIVIN S NATHAN D LARKIN M MCKITRICK C SCHWARZ S FISHER J KIPNES S WALZ B VAGUE P REEVES ML GOUDNER M THOMSON GP JAFFIOL C RENARD E LAUTON D JACQUESAPOSTOL D BRINGER J TAUBER JP HANAIREBROUTIN H REESJONES R ADOLFF S BAYS HA PFEIFER M CLARKE D IRSIGLER K FEINBOCH C HUTTER R MENDEL H DIGLAS J

Citation: M. Scavini et al., CATHETER SURVIVAL DURING LONG-TERM INSULIN THERAPY WITH AN IMPLANTED PROGRAMMABLE PUMP, Diabetes care, 20(4), 1997, pp. 610-613

Authors: HAARDT MJ BERNE C DORANGE C BRUZZO F SLAMA G SELAM JL

Citation: Mj. Haardt et al., LONG-TERM IMPACT OF CSII ON DIABETES CONTROL REVISITED - THE PARIS COHORT, Diabetes, 46, 1997, pp. 1260-1260

Authors: PINGET M JEANDIDIER N ORTEGA F WIX D MARGETAUX J FEINBOCK C DIGLAS J MENDL H IRSIGLER K SCAVINI M PETRELLA G TORRI M CRISTALLO M POZZA G LUDDEKE HJ GROTH T RENNER R HEPP KD SELAM JL HAARDT MJ BETHOUX JP DORANGE C SLAMA G VAGUE P LASSMANVAGUE V BELICAR P JOHANSSON M HAMMARBERG B FAHLSTROM U BASELIUS L SJOHOLM G

Citation: M. Pinget et al., MULTICENTER TRIAL OF A PROGRAMMABLE IMPLANTABLE INSULIN PUMP IN TYPE-I DIABETES, International journal of artificial organs, 18(6), 1995, pp. 322-325

Authors: HAARDT MJ SELAM JL SLAMA G BETHOUX JP DORANGE C MACE B RAMANICHE ML BRUZZO F

Citation: Mj. Haardt et al., A COST-BENEFIT COMPARISON OF INTENSIVE DIABETES MANAGEMENT WITH IMPLANTABLE PUMPS VERSUS MULTIPLE SUBCUTANEOUS INJECTIONS IN PATIENTS WITH TYPE-I DIABETES, Diabetes care, 17(8), 1994, pp. 847-851

Authors: SELAM JL HAARDT MJ BERNE C DORANGE C LANOE JL BETHOUX JP SLAMA G

Citation: Jl. Selam et al., COST-BENEFITS OF INTENSIVE INSULIN THERAP Y WITH EXTERNAL OR IMPLANTABLE PUMPS VS SUBCUTANEOUS INJECTIONS, Diabete et metabolisme, 19(5BIS), 1993, pp. 506-509